Nicaprin
94/100
This product looks safe
- Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
- 83% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
83%
Evidence Coverage
Supplement Facts — Evidence Check
250 mg
⚠️ Exceeds Tolerable Upper Intake Level by 7.1× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
500 mcg
✅ 1.2× RDA — within safe limits
📚 225 studies (Tier A: 10, B: 105)
4.5 mg
📊 3.5× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
1.4 mg
✅ 1.6× RDA — within safe limits
📚 36 studies (Tier A: 0, B: 11)
9 mg
✅ Within RDA (0.8× RDA of 11 mg)
📚 258 studies (Tier A: 6, B: 134)
Soliprin
125 mg
Other Ingredients
Iron Oxide
Magnesium Stearate
Methacrylic Acid Copolymer
Microcrystalline Cellulose
Polyethylene Glycol
Polyvinyl alcohol
Sodium Bicarbonate
Starch
Talc
Titanium Dioxide
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Dosage and administration: Usual adult dose is 1 to 2 tablets daily, or as directed by a physician. Please see package insert for full prescribing information.
⚠️ Warnings & Precautions
Tamper evident by foil seal under cap.
🧪 Formulation Notes
Indications and usage: This product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product.
Additional Information
NDC 57893-203-60 Rx only
Store between 15 degrees C and 30 degrees C (between 50 degrees F and 86 degrees F).
Product Details
UPC / SKU
3 57893 20360 6
DSLD Entry Date
2021-11-19
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Artesa Labs
DSLD ID
263268
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100